Default company panoramic image
Logo

Lymph/Axis

Lymph/Axis is developing new technologies to treat critical diseases such as heart failure, HIV and sepsis by acting on lymphatic fluid.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Mountain View, CA, USA
  • Currency USD
  • Founded March 2013
  • Employees 3

Company Summary

Many unsolved clinical needs involve disorders of the lymphatic system. AIDS, heart failure, and sepsis are all examples of critical conditions in which lymphatic cells or fluid play a key role. Until now direct access to lymphatic system has required a complicated surgical approach. Lymph/Axis has developed a minimally invasive method to access and manipulate lymphatic fluid using ultrasound imaging and a disposable catheter.

Team

  • Default avatar
    Matthew Callaghan
    Prinicpal

    Practicing physician and entrepreneur. Trained clinically at UCSF, graduate of Stanford's Biodesign Program, now consulting faculty in the Dept of Surgery at Stanford University. Previously founded OneBreath, Inc.

  • Default avatar
    Christian Eversull
    Principal

    Physician and principal at AUST Development, a medical device manufacturing and design group in Silicon Valley. Graduate of Stanford's Biodesign Program and Stanford Medical School, practicing physician at the Palo Alto VA Medical Center. Previously co-founder of Accumen Medical (Medtronic).

  • Default avatar
    Stephen Leeflang
    Principal

    Principal at AUST Development, a medical device manufacturing and design group in Silicon Valley. Graduate of Berkeley's Haas School of Business. Previously co-founder of Accumen Medical (Medtronic).

Advisors

  • Default avatar
    Evan Ng, Dorsey & Whitney LLP
    Lawyer
    Unconfirmed

Previous Investors

  • Default avatar
    Coulter Foundation, NCIIA (both non-dilutive grants)
    Unconfirmed